Treatment of gardnerella vaginalis vaginal colonization with amoxicillin.
Ended Awarded Last action
- Contract number
- HHSN27200011
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,127,677
Award facts
- Contract value 100% obligated
- $1,127,677.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Birmingham, AL 35294, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$511,082 | |
| Funding Only Action | -$244,886 | |
| Funding Only Action | -$17,186 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $174,580 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $702,398 | |
| Funding Only Action | $89,025 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $934,829 |
Show all 12
About this award
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) for a study on the treatment of Gardnerella vaginalis vaginal colonization with amoxicillin. The contract has a ceiling value of $1,127,677.42 and a period of performance ending on May 31, 2020. The contract is a delivery order and is priced on a cost-no-fee basis.
The contract includes several subcontracts. One is with the University of Arkansas for Medical Sciences (UAMS) for statistical support services. Another is with FHI 360, a nonprofit organization, to serve as the Operations Coordinating Center. A third subcontract is with Wake Forest University for protocol development, implementation, and analysis related to the treatment study.
This contract is not designated as a set-aside. As a leading research institution, UAB has extensive experience executing federal contracts and grants across a wide range of biomedical and healthcare areas for various government agencies.
Quick answers
Who was awarded contract HHSN27200011?
HHSN27200011 was awarded to University Of Alabama At Birmingham by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 5, 2016.
How much is contract HHSN27200011 worth?
The government has obligated $1,127,677 on HHSN27200011.
Is contract HHSN27200011 an order under another contract?
Yes. HHSN27200011 is a delivery order under HHSN272201300012I, an indefinite delivery contract.
Was contract HHSN27200011 competed?
The extent of competition for HHSN27200011 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award